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that the prevalence of EBOV in these 
tested bat species is greater than that 
previously detected in E. helvum bats 
(1/262 serum samples) (1). The higher 
estimated prevalence in these species 
occurred despite the fact that E. helvum 
bats live in large colonies comprising 
several million animals, which make 
the species an ideal host for acute 
RNA virus infections. The relatively 
low seroprevalence of EBOV among 
E. helvum bats compared with that 
among sympatric species is contrary 
to our fi ndings for a lyssavirus and 
an uncharacterized henipavirus 
(3,4). Our results, therefore, lead us 
to question what factors (e.g., host, 
ecologic) limit EBOV circulation 
in straw-colored fruit bats. Virus 
isolation is required to characterize 
EBOVs circulating among fruit bats 
in Ghana, and additional testing, 
including longitudinal sampling of 
bats, is required to further investigate 
the epidemiology of EBOV in West 
Africa. Possible public health threats 
should also be investigated and 
addressed. These initial fi ndings, 
however, suggest that the risk for 
human infection with EBOV might 
be greater from bat-human contact 
in rural and forest settings than from 
urban-roosting E. helvum bats.
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Outbreak-
associated Novel 
Duck Reovirus, 
China, 2011
To the Editor: In 2011, an 
unidentifi ed disease in Pekin ducks 
(Anas platyrhynchos) was reported 
in People’s Republic of China. The 
infection caused death in 40% of 
ducks of various age and 35%–40% 
mortality in different fl ocks. Clinical 
signs included unstable gait, weakness 
in legs, and diarrhea. At necropsy, 
large necrotic foci were observed in 
the spleens. All classical endemic 
and emerging viruses, such as duck 
enteritis virus, duck hepatitis virus, 
duck fl avivirus, duck parvovirus, 
and avian infl uenza virus, could 
be excluded as the causative agent 
by PCR and serologic methods. To 
identify the cause of the disease, we 
tested tissue from affected ducks and 
subsequently isolated a novel duck-
pathogenic orthoreovirus from the 
livers of affected ducks.
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Avian orthoreoviruses (ARVs) 
belong to the family Reoviridae, 
genus Orthoreovirus (1). The virions 
are nonenveloped, with icosahedral 
symmetry and a double capsid 
containing 10 double-stranded RNA 
segments that can be separated by 
polyacrylamide gel electrophoresis 
into 3 size classes: large (L1–L3), 
medium (M1–M3), and small (S1–S4) 
(2,3). ARVs cause a range of diseases 
in chicken, including viral arthritis/
tenosynovitis, and are associated 
with respiratory disease, enteric 
disease, inclusion body hepatitis, 
hydropericardium, runting stunting 
syndrome, malabsorption syndrome, 
and sudden death. ARVs also have 
been isolated from the Muscovy duck 
(Cairina moschata). Muscovy duck 
reovirus infection caused illness in 
30% and death in 20% of ducks on 
poultry farms in Israel (4). In China, 
reovirus infection has been reported in 
Muscovy ducklings, with a resulting 
death rate of 10%–30% since 1997 
(5). The isolated reovirus was highly 
pathogenic to 1-day-old Muscovy 
ducklings by experimental infection. 
However, the Muscovy duck reovirus 
isolate was nonpathogenic for Pekin 
ducks when inoculated subcutaneously 
(4).
Since 2007, three isolates of 
orthoreovirus were confi rmed in 
Pekin ducks from several duck farms 
in China. However, experiment 
infection with the isolates did not 
cause death (6). In 2011, farmers and 
veterinarians in China reported to the 
Animal Health Services and National 
Research Institutes an unidentifi ed 
disease in ducks that spread rapidly 
around the county. We conducted 
further investigation to identify the 
causative agent of this disease. The 
diseased ducks showed depression 
and leg weakness. Large necrotic 
foci were observed in the spleens 
of the dead ducks. Histopathologic 
examination showed necrotic foci 
and granulomas in the spleen. Focal 
hepatic necrosis and proliferation of 
bile ducts were seen in the liver. Virus 
isolation from liver homogenate was 
conducted in duck embryo fi broblast 
cultures. At 48 hours after infection, a 
strong cytopathic effect was observed, 
including syncytium formation. 
All duck embryos experimentally 
infected with the isolate died within 
48–72 hours after infection. The dead 
embryos showed swollen livers with 
petechial hemorrhages. Spherical, 
spiked virus particles, consistent 
with those of members of the family 
Reoviridae, were observed by electron 
microscopy. As reported (7), the 
diameter of the particles was ≈85 nm 
(online Appendix Figure, wwwnc.
cdc.gov/EID/article/18/7/12-0190-
FA1.htm). The RNA extracted from 
DRV-infected duck embryo fi broblast 
cultures showed 10 dsRNA segments in 
3 size classes (L1–3, M1–3, and S1–4) 
on polyacrylamide gel electrophoresis. 
The isolate was designated as novel 
duck reovirus, DRV-TH11. The 
pathogenicity of DRV-TH11 was 
tested by infecting 10-day-old Pekin 
ducks subcutaneously at a dose of 4 × 
104.5 50% tissue culture infective dose. 
Experimental infection caused death 
on day 3 after infection. The clinical 
signs and histopathologic examination 
show the same features as the naturally 
infected ducks.
For phylogenetic analyses, the 
S2 gene was amplifi ed by reverse 
transcription PCR with avian reovirus–
specifi c primers. The complete 
sequence of the S2 gene (GenBank 
accession no. JQ664689) was aligned 
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Figure. Phylogenetic relationship between DRV-TH11 isolate and orthoreovirus of the 
avian orthoreovirus (ARV) and mammalian orthoreovirus (MRV). ARV includes chicken 
reovirus, Muscovy duck reovirus, and Pekin duck reovirus. GenBank accession numbers 
of the sequences in the analysis are indicated in the tree. The neighbor-joining tree is 
based on the complete sequence of s2 gene (1,251 nt). Numbers at nodes represent the 
percentage of 1,000 bootstrap replicates (values <50 are not shown). Scale bar indicates a 
branch length corresponding to 100 character-state changes.
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with 30 published orthoreovirus 
sequences, including data on all 3 
newly obtained sequences from Pekin 
duck reovirus in China in 2008 and 
2011. Phylogenetic relationship was 
assessed by using the neighbor-joining 
method based on a Tamura 3-parameter 
model and bootstrap analysis (1,000 
replicates) as implemented in MEGA5 
(8). The phylogenetic tree shows that 
the complete sequence of S2 gene 
is distinct but clusters closely with 
sequences from all 3 Pekin duck 
isolates within the ARVs serogroup, 
which suggests that the novel virus 
is an ARV-like virus within the genus 
Orthoreovirus (Figure).
In summary, we isolated a novel 
duck-pathogenic orthoreovirus from 
the liver of affected Pekin ducks. 
The regression test in its natural host 
animal showed that the newly isolated 
virus caused their deaths. This fi nding 
highlights the need to prevent and 
control this highly transmissible 
infectious agent. Further study is 
needed to determine what role the 
newly isolated DRV played in the 
2011 outbreaks on many of the duck 
farms in China.
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Considerations for 
Oral Cholera 
Vaccine Use 
during Outbreak 
after Earthquake 
in Haiti, 2010–2011
To the Editor: We wish to thank 
Date et al. for their clear discussion of 
the arguments against the use of oral 
cholera vaccines (OCVs) in Haiti in 
2010–11 (1). The epidemic curve in 
their article suggests that the control 
activities had an effect on mortality 
rates, resulting in a decrease in case-
fatality rates to <1%. This fi nding is 
a remarkable success not achieved 
during the recent cholera outbreak 
in Zimbabwe that affected 98,531 
persons, of whom 4,282 (4.3%) 
died (2). However, the article does 
not discuss the lack of effect of the 
control measures in Haiti on the 
spread of the epidemic. Considering 
the failure of containment, it would 
have been interesting to read how the 
authors judge the recommendation 
not to vaccinate, with the benefi t of 
hindsight.
The authors list a catalog of 
arguments against the use of OCVs 
in outbreaks. These included the 
priority of water provision and 
cholera treatment measures, how 
modeling data provided no convincing 
justifi cation for vaccination cam-
paigns, how mobile populations 
cannot be trusted to take 2 doses, the 
time for a 2-dose vaccine to generate 
immunity, the logistic challenges in 
a setting of inadequate infrastructure 
and human resources, the cold 
chain requirements, the diffi culty 
in transport of bulky vaccine, clean 
water requirements for the buffer, civil 
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